Progress in Neuro-Psychopharmacology and Biological Psychiatry 1994-03-01

Correlation of clinical response (PANSS) and plasma levels of haloperidol and reduced haloperidol in schizophrenia.

J M Leroux, E Elia, M Jacquet, J Pommery, J C Levron, P Bouhours, F Erb, D Sechter

Index: Prog. Neuropsychopharmacol. Biol. Psychiatry 18(2) , 347-53, (1994)

Full Text: HTML

Abstract

1. The authors attempted to correlate plasma concentrations in H/rH and clinical efficacy from 8 schizophrenic patients (DSM IIIR) on H. 2. No significant correlations were found between H, rH plasma levels and positive and negative subscale for each patient. 3. The authors observed an opposite evolution concerning the mean results between plasma concentrations and PANSS total score.


Related Compounds

Related Articles:

Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.

2009-07-01

[Psychopharmacology 205 , 21-33, (2009)]

Determination of haloperidol and reduced haloperidol in human serum by liquid chromatography after fluorescence labeling based on the Suzuki coupling reaction.

2006-10-01

[Anal. Bioanal. Chem 386(3) , 719-24, (2006)]

Plasma reduced haloperidol/haloperidol ratios in schizophrenic patients treated with high dosages of haloperidol.

1994-06-01

[Eur. Neuropsychopharmacol. 4(2) , 119-26, (1994)]

Reduced haloperidol does not interfere with the antipsychotic activity of haloperidol in the treatment of acute schizophrenia.

1999-07-01

[Int. Clin. Psychopharmacol. 14(4) , 219-28, (1999)]

Effect of a genetic polymorphism of CYP1A2 inducibility on the steady state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia.

2000-06-01

[Ther. Drug Monit. 22(3) , 245-9, (2000)]

More Articles...